Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Zhou, Yuan ^a   Wei, Yutao ^a,b   Wang, Lei ^c   Wang, Xianguo ^a   Du, Xinling ^a   Sun, Zongquan ^a   Dong, Nianguo ^a   Chen, Xinzhong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHIHEZI UNIVERSITY   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, HUMAN; AUTACOID; IL6 PROTEIN, HUMAN; MESSENGER RNA; TLR4 PROTEIN, HUMAN;

ADIPOSE TISSUE; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; EPICARDIUM; HUMAN; HUMAN TISSUE; INFLAMMATION; MACROPHAGE ACTIVATION; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; APOPTOSIS; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CHINA; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; METHODOLOGY; MIDDLE AGED; MONOCYTE; PATHOLOGY; PERICARDIUM; TIME; UPREGULATION;

ADIPONECTIN; ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; APOPTOSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHINA; CORONARY ARTERY DISEASE; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MACROPHAGES; MIDDLE AGED; MONOCYTES; PERICARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 78651258851     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-2     Document Type: Article

References (33)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. 10.1038/372425a0, 7984236.
2. Scherer P, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749. 10.1074/jbc.270.45.26746, 7592907.
3. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banergee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312. 10.1038/35053000, 11201732.
4. Samad F, Loskutoff DJ. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 1996, 2:568-582. 2230189, 8898373.
5. Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997, 46:860-867. 10.2337/diabetes.46.5.860, 9133556.
6. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005, 107:198-211. 10.1016/j.pharmthera.2005.04.001, 15907343.
7. Xu H, Uysal KT, Becherer JD, Arner P, Hotamisligil GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes 2002, 51:1876-1883. 10.2337/diabetes.51.6.1876, 12031976.
8. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, Feingold KR. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995, 136:2143-2149. 10.1210/en.136.5.2143, 7720663.
9. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005, 2:536-543. 10.1038/ncpcardio0319, 16186852.
10. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP. Visceral obesity and the heart. Int J Biochem Cell Biol 2008, 40:821-836. 10.1016/j.biocel.2007.12.001, 18201922.
11. Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol 2008, 23:591-598. 10.1097/HCO.0b013e328313133a, 18830075.
12. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491. 10.1074/jbc.M206083200, 12138120.
13. Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev 2009, 10:269-279. 10.1111/j.1467-789X.2009.00571.x, 19389061.
14. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993, 81:1607-1613.
15. Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, Vitale D, Tritapepe L, Letizia C. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res 2009, 41:227-231. 10.1055/s-0028-1100412, 19003726.
16. Zhang D, Hetherington C, Tan S, Dziennis S, Gonzalez D, Chen H, Tenen D. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem 1994, 269:11425-11434.
17. Yudkin J, Kumari M, Humphries S, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214. 10.1016/S0021-9150(99)00463-3, 10657556.
18. Fruebis J, Tsao T, Javorschi S, Ebbets-Reed D, Erickson M, Yen F, Bihain B, Lodish H. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001, 98:2005-2010. 10.1073/pnas.041591798, 29372, 11172066.
19. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, Mcternan PG. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006, 5:1-7. 10.1186/1475-2840-5-1, 1352345, 16412224.
20. Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 2007, 354:45-49. 10.1016/j.bbrc.2006.12.190, 17210129.
21. Coenen K, Gruen M, Lee-Young R, Puglisi MJ, Wasserman DH, Hasty AH. Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia 2009, 52:318-328. 10.1007/s00125-008-1221-7, 2615827, 19052722.
22. Newby AC, George SJ, Ismail Y, Johnson JL, Sala-Newby GB, Thomas AC. Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost 2009, 101:1006-1011. 2850555, 19492140.
23. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996, 120:803-812.
24. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, ApM 1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289. 10.1006/bbrc.1996.0587, 8619847.
25. Saito K, Tobe T, Minoshima S, Asakawa S, Sumiya J, Yoda M, Nakano Y, Shimizu N, Tomita M. Organization of the gene for gelatin-binding protein (GBP28). Gene 1999, 229:67-73. 10.1016/S0378-1119(99)00041-4, 10095105.
26. Tuttolomondo A, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo Sasso B, Guercio G, Diana G, Ciaccio M, Licata G, Pinto A. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol 2010, 9:50. 10.1186/1475-2840-9-50, 2946274, 20836881.
27. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J 2009, 73:608-614. 10.1253/circj.CJ-09-0057, 19261992.
28. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008, 32:268-274. 10.1038/sj.ijo.0803726, 17878891.
29. Iacobellis G, Cotesta D, Petramala L, De Santis V, Vitale D, Tritapepe L, Letizia C. Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol 2010, 144:160-163. 10.1016/j.ijcard.2008.12.155, 19174315.
30. Park JS, Ahn SG, Hwang JW, Lim HS, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH. Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol 2010, 9:29. 10.1186/1475-2840-9-29, 2913996, 20604967.
31. Febbraio M, Silverstein RL. CD36: implications in cardiovascular disease. Int J Biochem Cell Biol 2007, 39:2012-2030. 10.1016/j.biocel.2007.03.012, 2034445, 17466567.
32. Lemieux I, Poirier P, Bergeron J, Almeras N, Lamarche B, Cantin B, Dagenais GR, Despres JP. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?. Can J Cardiol 2007, 23(Suppl B):23B-31B. 2794461, 17932584.
33. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O, Navarrete-Lopez M, Aguilar-Salinas CA. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol 2010, 9:26. 10.1186/1475-2840-9-26, 2902434, 20573249.